Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhao, Chunli ^a   Farruggio, Alfonso P ^a   Bjornson, Christopher R R ^a   Chavez, Christopher L ^a   Geisinger, Jonathan M ^a   Neal, Tawny L ^a   Karow, Marisa ^a   Calos, Michele P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CRE RESOLVASE; DYSTROPHIN; INTEGRASE; PROTEIN BXB1; RECOMBINASE; RESOLVASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN GENE; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENE LOCATION; GENETIC ENGINEERING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; DYSTROPHIN; GENETIC ENGINEERING; GENETIC THERAPY; INDUCED PLURIPOTENT STEM CELLS; INTEGRASES; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, DUCHENNE; NUCLEAR REPROGRAMMING;

EID: 84899723951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096279     Document Type: Article

References (46)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131: 861-872. doi:10.1016/j.cell.2007.11.019. (Pubitemid 350138099)
2. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. doi:16/j.cell.2006.07.024.
3. Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, et al. (2013) Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494: 100-104. doi:10.1038/ nature11807.
4. Yamanaka S (2009) A fresh look at iPS cells. Cell 137: 13-17. doi:10.1016/j.cell.2009.03.034.
5. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G (2010) Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120: 11-19. doi:10.1172/JCI40373.
6. Bushby K (2009) Diagnosis and management of the limb girdle muscular dystrophies. Pract Neurol 9: 314-323. doi:10.1136/jnnp.2009.193938.
7. Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53: 219-228. doi:10.1016/0092-8674(88)90383-2.
8. Nowak KJ, Davies KE (2004) Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep 5: 872-876. doi:10.1038/sj.embor.7400221. (Pubitemid 350011231)
9. Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, et al. (2011) Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther 19: 830-840. doi:10.1038/mt.2011.59.
10. Barberi T, Bradbury M, Dincer Z, Panagiotakos G, Socci ND, et al. (2007) Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13: 642-648. doi:10.1038/nm1533. (Pubitemid 46828477)
11. Chang H, Yoshimoto M, Umeda K, Iwasa T, Mizuno Y, et al. (2009) Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J 23: 1907-1919. doi:10.1096/fj.08-123661.
12. Darabi R, Gehlbach K, Bachoo RM, Kamath S, Osawa M, et al. (2008) Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 14: 134-143. doi:10.1038/nm1705. (Pubitemid 351214552)
13. Darabi R, Pan W, Bosnakovski D, Baik J, Kyba M, et al. (2011) Functional myogenic engraftment from mouse iPS cells. Stem Cell Rev Reports 7: 948-957. doi:10.1007/s12015-011-9258-2.
14. Darabi R, Santos FNC, Filareto A, Pan W, Koene R, et al. (2011) Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors. STEM CELLS 29: 777-790. doi:10.1002/stem.625.
15. Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, et al. (2012) Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10: 610-619. doi:10.1016/j.stem.2012.02.015.
16. Filareto A, Parker S, Darabi R, Borges L, Iacovino M, et al. (2013) An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun 4: 1549. doi:10.1038/ncomms2550.
17. Goudenege S, Lebel C, Huot NB, Dufour C, Fujii I, et al. (2012) Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol Ther 20: 2153-2167. doi:10.1038/mt.2012.188.
18. Kazuki Y, Hiratsuka M, Takiguchi M, Osaki M, Kajitani N, et al. (2009) Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol Ther 18: 386-393. doi:10.1038/mt.2009.274.
19. Mizuno Y, Chang H, Umeda K, Niwa A, Iwasa T, et al. (2010) Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 24: 2245-2253. doi:10.1096/fj.09-137174.
20. Tedesco FS, Gerli MFM, Perani L, Benedetti S, Ungaro F, et al. (2012) Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med 4: 140ra89-140ra89. doi:10.1126/scitranslmed.3003541.
21. Matsuda T, Cepko CL (2007) Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci 104: 1027-1032. doi:10.1073/pnas.0610155104. (Pubitemid 46154730)
22. Keravala A, Chavez CL, Hu G, Woodard LE, Monahan PE, et al. (2011) Long-term phenotypic correction in factor IX knockout mice by using phiC31 integrase-mediated gene therapy. Gene Ther 18: 842-848. doi:10.1038/gt.2011.31.
23. Groth AC, Olivares EC, Thyagarajan B, Calos MP (2000) A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci U S A 97: 5995-6000. (Pubitemid 30367512)
24. Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S (2010) Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci 107: 14152-14157. doi:10.1073/pnas.1009374107.
25. Donello JE, Loeb JE, Hope TJ (1998) Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72: 5085-5092. (Pubitemid 28215689)
26. Chalberg TW, Portlock JL, Olivares EC, Thyagarajan B, Kirby PJ, et al. (2006) Integration specificity of phage phiC31 integrase in the human genome. J Mol Biol 357: 28-48. doi:10.1016/j.jmb.2005.11.098. (Pubitemid 43339312)
27. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21: 3926-3934. doi:10.1128/MCB.21.12.3926-3934.2001. (Pubitemid 32476454)
28. Keravala A, Groth A, Jarrahian S, Thyagarajan B, Hoyt J, et al. (2006) A diversity of serine phage integrases mediate site-specific recombination in mammalian cells. Mol Genet Genomics 276: 135-146. doi:10.1007/s00438-006-0129-5. (Pubitemid 44079953)
29. Nagy A (2000) Cre recombinase: The universal reagent for genome tailoring. genesis 26: 99-109. doi:10.1002/(SICI)1526-968X(200002)26:2〈99:: AID-GENE1〉3.0.CO;2-B.
30. Sauer B, Henderson N (1989) Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 17: 147-161. doi:10.1093/nar/17.1.147. (Pubitemid 19030024)
31. Papapetrou EP, Lee G, Malani N, Setty M, Riviere I, et al. (2011) Genomic safe harbors permit high b-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 29: 73-78. doi:10.1038/nbt.1717.
32. Sommer CA, Sommer AG, Longmire TA, Christodoulou C, Thomas DD, et al. (2010) Excision of Reprogramming Transgenes Improves the Differentiation Potential of iPS Cells Generated with a Single Excisable Vector. STEM CELLS 28: 64-74. doi:10.1002/stem.255.
33. Banks GB, Combs AC, Chamberlain JS (2010) Sequencing protocols to genotype mdx, mdx4cv, and mdx5cv mice. Muscle Nerve 42: 268-270. doi:10.1002/mus.21700.
34. Fukada S, Higuchi S, Segawa M, Koda K, Yamamoto Y, et al. (2004) Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp Cell Res 296: 245-255. doi:10.1016/j.yexcr.2004.02.018. (Pubitemid 38624645)
35. Cazzella V, Martone J, Pinnarò C, Santini T, Twayana SS, et al. (2012) Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts. Mol Ther 20: 2134-2142. doi:10.1038/mt.2012.178.
36. Boldrin L, Neal A, Zammit PS, Muntoni F, Morgan JE (2012) Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated. Stem Cells 30: 1971-1984. doi:10.1002/stem.1158.
37. Danko I, Chapman V, Wolff JA (1992) The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr Res 32: 128-131. doi:10.1203/00006450-199207000-00025.
38. Hacein-Bey-Abina S, Kalle CV, Schmidt M, McCormack MP, Wulffraat N, et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419. doi:10.1126/science.1088547. (Pubitemid 37296260)
39. Karow M, Chavez CL, Farruggio AP, Geisinger JM, Keravala A, et al. (2011) Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA. Stem Cells 29: 1696-1704. doi:10.1002/stem.730.
40. Ye L, Chang JC, Lin C, Qi Z, Yu J, et al. (2010) Generation of induced pluripotent stem cells using site-specific integration with phage integrase. Proc Natl Acad Sci 107: 19467-19472. doi:10.1073/pnas.1012677107.
41. Merkl C, Saalfrank A, Riesen N, Kühn R, Pertek A, et al. (2013) Efficient generation of rat induced pluripotent stem cells using a non-viral inducible vector. PLoS ONE 8: e55170. doi:10.1371/journal.pone.0055170.
42. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, et al. (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8: 409-412. doi:10.1038/nmeth.1591.
43. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, et al. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801. doi:10.1126/science.1172482.
44. Warren L, Manos PD, Ahfeldt T, Loh Y-H, Li H, et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630. doi:10.1016/j.stem.2010.08.012.
45. Rohwedel J, Maltsev V, Bober E, Arnold H-H, Hescheler J, et al. (1994) Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: Developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 164: 87-101. doi:10.1006/dbio.1994.1182. (Pubitemid 24234337)
46. Rosenblatt JD, Lunt AI, Parry DJ, Partridge TA (1995) Culturing satellite cells from living single muscle fiber explants. Vitro Cell Dev Biol - Anim 31: 773-779. doi:10.1007/BF02634119.